PROF: Profound Medical Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
Stocks in this Quantisnow insightHealth Care
Historical context for PROF
Across the 25 sessions after earlier PROF headlines, the stock closed higher 12 times and lower 13 times, with a median move of 2.5% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | PROF | SPY |
|---|---|---|---|
| May 14, 2026 | Profound to Showcase TULSA-PRO®, the TULSA Procedure™ and the Future of iMRI at AUA2026 | +1.4% | +0.8% |
| May 8, 2026 | Profound Medical Reports Strong First Quarter 2026 Financial Results | -4.3% | +0.8% |
| Apr 16, 2026 | Profound Medical to Release First Quarter 2026 Financial Results on May 7 – Conference Call to Follow | +3.1% | +0.2% |
| Apr 14, 2026 | Profound Medical to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference | -0.2% | +1.2% |
| Mar 27, 2026 | Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure™ Milestone | -1.7% | -1.7% |
| Mar 13, 2026 | CAPTAIN Trial Comparing Profound's MRI-Guided TULSA Procedure™ to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence | -0.7% | -0.6% |
Quantisnow market dataNASDAQ
PROF
Profound Medical Corp.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
Get push alerts for PROF
Full PROF profile on Quantisnow Follow PROF and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time